


A persistent chest infection, a stubborn sinus problem, or a recurring urinary infection can wear a patient down. When common antibiotics fail, doctors turn to stronger oral options that still work against resistant bacteria. Faropenem (300mg) is an oral penem antibiotic that doctors prescribe for moderate bacterial infections. This guide explains how it works, where doctors use it, and which safety rules matter. It also shows why this product attracts distributors who want to join a PCD pharma franchise company in India.
Faropenem is an oral penem antibiotic from the beta-lactam family, the same broad family as penicillins and cephalosporins. Bacteria produce beta-lactamase enzymes to destroy many common antibiotics. Penems resist many of these enzymes, so they keep working where simpler drugs fail.
The 300 mg tablet gives doctors a higher-strength option. They choose it when an infection needs stronger coverage or when a patient fits a higher-dose schedule.
Bacteria need a strong cell wall to survive. Faropenem binds to proteins in the bacterial cell wall and blocks wall construction. The wall weakens, and the bacterium dies.
Faropenem stays stable against many beta-lactamase enzymes. It acts on a wide range of Gram-positive and Gram-negative bacteria and on some anaerobes. This breadth makes it useful when an infection involves more than one organism.
Doctors prescribe Faropenem for bacterial infections such as:
Antibiotics work only against bacteria. They do not treat colds, flu, or other viral illnesses.
| Benefit | What It Means for the Patient |
| Oral penem | Offers a strong option without injections |
| Beta-lactamase stability | Works against many resistant bacteria |
| Broad coverage | Acts on several common infection-causing organisms |
| Higher strength | Gives doctors a flexible dosing choice |
| Familiar class | Doctors understand beta-lactam safety and use well |
A doctor sets the dose after checking the infection type, severity, and kidney function. In general:
Stopping early lets surviving bacteria multiply and grow resistant. Patients should never share antibiotics or save leftover tablets.
Antimicrobial resistance (AMR) is a serious public health problem in India and worldwide. Overuse and misuse of antibiotics speed it up. Doctors therefore reserve stronger antibiotics for cases that need them and confirm the need for treatment before prescribing.
Franchise partners share this responsibility. Promote Faropenem responsibly, give accurate prescribing information, and never encourage use without a prescription.
Honest safety messaging builds trust with doctors and patients.
This medicine needs a prescription. Self-medication carries real risk.
Farolick-300 | Ojana Pharmaceutical brings this higher-strength antibiotic to franchise partners. It enters the anti-infective segment, one of the largest therapy areas in India.
Why does this product suit distributors?
The Indian pharmaceutical industry keeps expanding, which creates room for new franchise partners. Industry sources report these trends:
Note: Market figures change every year. Verify the latest numbers on IBEF, the Department of Pharmaceuticals, ICMR, or IQVIA before you publish.
A PCD pharma franchise company in India allows you to market branded medicines in your own territory. PCD means Propaganda Cum Distribution. You promote the company’s products, handle local sales, and build your own business identity.
This model suits medical representatives, chemists, distributors, and first-time entrepreneurs.
Buyers often search for the top 10 PCD pharma franchise companies in India before they commit. No official ranking exists, so judge each company on facts. Use this checklist:
A company that meets most of these points deserves a place on your shortlist.
In 2026, doctors continue to prescribe Faropenem (300mg) for bacterial sinusitis, bronchitis flare-ups, pneumonia, urinary tract infections, and skin infections. It works only against bacteria, not viruses.
Patients should take Faropenem (300mg) exactly as their doctor directs, usually after food, and finish the full course. Current 2026 stewardship guidance warns against stopping early or sharing tablets.
Yes. In 2026, Faropenem (300mg) remains a prescription antibiotic in India. Chemists should dispense it only against a valid prescription.
Users in 2026 may notice diarrhoea, nausea, abdominal discomfort, headache, or rash with Faropenem (300mg). Patients should contact a doctor if symptoms continue or worsen.
Safety guidance in 2026 tells people with allergy to penicillins, cephalosporins, or other beta-lactams to avoid Faropenem (300mg). Pregnant and breastfeeding women should consult a doctor first.
Farolick-300 | Ojana Pharmaceutical is a branded tablet that contains Faropenem (300mg). The company offers it to franchise partners who want an anti-infective product in their range.
Demand for anti-infectives stays strong in 2026 as the Indian pharma market moves toward its USD 130 billion target for 2030. Faropenem (300mg) gives a PCD pharma franchise company in India a reliable, repeat-prescription product.
Check licences, GMP certification, territory rights, and batch quality reports. In 2026, choose a company that supplies Faropenem (300mg) with transparent terms and reliable delivery.
Faropenem (300mg) gives doctors a higher-strength oral penem option for bacterial infections, and its beta-lactamase stability adds value. For entrepreneurs, Farolick-300 | Ojana Pharmaceutical opens a strong path into the anti-infective segment. Pick your franchise partner with care, verify every claim, and promote the product with responsible, prescription-only messaging.
Disclaimer: This article provides general information only. It does not replace professional medical advice. Always consult a qualified doctor before you use any medicine.